PRPH2/RDS and ROM-1: Historical context, current views and future considerations
- PMID:26773759
- PMCID: PMC4842342
- DOI: 10.1016/j.preteyeres.2015.12.002
PRPH2/RDS and ROM-1: Historical context, current views and future considerations
Abstract
Peripherin 2 (PRPH2), also known as RDS (retinal degeneration slow) is a photoreceptor specific glycoprotein which is essential for normal photoreceptor health and vision. PRPH2/RDS is necessary for the proper formation of both rod and cone photoreceptor outer segments, the organelle specialized for visual transduction. When PRPH2/RDS is defective or absent, outer segments become disorganized or fail to form entirely and the photoreceptors subsequently degenerate. Multiple PRPH2/RDS disease-causing mutations have been found in humans, and they are associated with various blinding diseases of the retina such as macular degeneration and retinitis pigmentosa, the vast majority of which are inherited dominantly, though recessive LCA and digenic RP have also been associated with RDS mutations. Since its initial discovery, the scientific community has dedicated a considerable amount of effort to understanding the molecular function and disease mechanisms of PRPH2/RDS. This work has led to an understanding of how the PRPH2/RDS molecule assembles into complexes and functions as a necessary part of the machinery that forms new outer segment discs, as well as leading to fundamental discoveries about the mechanisms that underlie OS biogenesis. Here we discuss PRPH2/RDS-associated research and how experimental results have driven the understanding of the PRPH2/RDS protein and its role in human disease.
Keywords: Photoreceptors PRPH2; RDS; ROM-1; Retinal degeneration; Tetraspanin.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures





Similar articles
- Retinal Degeneration Slow (RDS) Glycosylation Plays a Role in Cone Function and in the Regulation of RDS·ROM-1 Protein Complex Formation.Stuck MW, Conley SM, Naash MI.Stuck MW, et al.J Biol Chem. 2015 Nov 13;290(46):27901-13. doi: 10.1074/jbc.M115.683698. Epub 2015 Sep 29.J Biol Chem. 2015.PMID:26420485Free PMC article.
- Novel molecular mechanisms for Prph2-associated pattern dystrophy.Chakraborty D, Strayve DG, Makia MS, Conley SM, Kakahel M, Al-Ubaidi MR, Naash MI.Chakraborty D, et al.FASEB J. 2020 Jan;34(1):1211-1230. doi: 10.1096/fj.201901888R. Epub 2019 Nov 29.FASEB J. 2020.PMID:31914632Free PMC article.
- Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDS.Conley SM, Stuck MW, Burnett JL, Chakraborty D, Azadi S, Fliesler SJ, Naash MI.Conley SM, et al.Hum Mol Genet. 2014 Jun 15;23(12):3102-14. doi: 10.1093/hmg/ddu014. Epub 2014 Jan 25.Hum Mol Genet. 2014.PMID:24463884Free PMC article.
- The Interplay between Peripherin 2 Complex Formation and Degenerative Retinal Diseases.Tebbe L, Kakakhel M, Makia MS, Al-Ubaidi MR, Naash MI.Tebbe L, et al.Cells. 2020 Mar 24;9(3):784. doi: 10.3390/cells9030784.Cells. 2020.PMID:32213850Free PMC article.Review.
- Gene therapy for PRPH2-associated ocular disease: challenges and prospects.Conley SM, Naash MI.Conley SM, et al.Cold Spring Harb Perspect Med. 2014 Aug 28;4(11):a017376. doi: 10.1101/cshperspect.a017376.Cold Spring Harb Perspect Med. 2014.PMID:25167981Free PMC article.Review.
Cited by
- PRPH2-Related Retinal Diseases: Broadening the Clinical Spectrum and Describing a New Mutation.Coco-Martin RM, Sanchez-Tocino HT, Desco C, Usategui-Martín R, Tellería JJ.Coco-Martin RM, et al.Genes (Basel). 2020 Jul 9;11(7):773. doi: 10.3390/genes11070773.Genes (Basel). 2020.PMID:32660024Free PMC article.
- Ultrathin micromolded 3D scaffolds for high-density photoreceptor layer reconstruction.Lee IK, Ludwig AL, Phillips MJ, Lee J, Xie R, Sajdak BS, Jager LD, Gong S, Gamm DM, Ma Z.Lee IK, et al.Sci Adv. 2021 Apr 21;7(17):eabf0344. doi: 10.1126/sciadv.abf0344. Print 2021 Apr.Sci Adv. 2021.PMID:33883135Free PMC article.
- NGS Analysis for Molecular Diagnosis of Retinitis Pigmentosa (RP): Detection of a Novel Variant inPRPH2 Gene.Strafella C, Caputo V, Pagliaroli G, Iozzo N, Campoli G, Carboni S, Peconi C, Galota RM, Zampatti S, Minozzi G, Novelli G, Giardina E, Cascella R.Strafella C, et al.Genes (Basel). 2019 Oct 12;10(10):792. doi: 10.3390/genes10100792.Genes (Basel). 2019.PMID:31614793Free PMC article.
- Influence of Clinical and Genetic Factors on the Progression of Age-Related Macular Degeneration: A 3-Year Follow-Up.Krytkowska E, Ulańczyk Z, Grabowicz A, Safranow K, Kawa MP, Pałucha A, Wąsowska A, Matczyńska E, Boguszewska-Chachulska A, Machalińska A.Krytkowska E, et al.J Clin Med. 2023 Mar 1;12(5):1963. doi: 10.3390/jcm12051963.J Clin Med. 2023.PMID:36902750Free PMC article.
- Tetraspanins as Potential Modulators of Glutamatergic Synaptic Function.Becic A, Leifeld J, Shaukat J, Hollmann M.Becic A, et al.Front Mol Neurosci. 2022 Jan 3;14:801882. doi: 10.3389/fnmol.2021.801882. eCollection 2021.Front Mol Neurosci. 2022.PMID:35046772Free PMC article.Review.
References
- Ali RR, Sarra GM, Stephens C, Alwis MD, Bainbridge JW, Munro PM, Fauser S, Reichel MB, Kinnon C, Hunt DM, Bhattacharya SS, Thrasher AJ. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet. 2000;25:306–310. - PubMed
- Anderson DH, Fisher SK, Steinberg RH. Mammalian cones: disc shedding, phagocytosis, and renewal. Invest. Ophthalmol. Vis. Sci. 1978;17:117–133. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials